Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway. (2018). Biomolecules and Biomedicine, 18(2), 162-169. https://doi.org/10.17305/bjbms.2018.2400